ZLN005 and metformin cell toxicity. by Joel R. Frandsen (20685133)

Subjects:

ZLN005 and metformin toxicity in MAC. by Joel R. Frandsen (20685133)

Subjects:

Metformin increases PGC-1α and TFAM expression. by Joel R. Frandsen (20685133)

Subjects:

ZLN005 increases PGC-1α and TFAM expression. by Joel R. Frandsen (20685133)

Subjects:

Metformin rescues PGC-1α expression in presence of inhibitor. by Joel R. Frandsen (20685133)

Subjects:

Metformin and ZLN005 facilitate increased phagocytic uptake and intracellular killing of MAB. by Joel R. Frandsen (20685133)

Subjects:

NTM infection induces mitochondrial damage and reduces mitochondria number. by Joel R. Frandsen (20685133)

Subjects:

Metformin and ZLN005 attenuate MAC-mediated mitochondrial membrane potential damage. by Joel R. Frandsen (20685133)

Subjects:

Patient demographics. by Yongwoo Lee (2265172)

Subjects:

Flowchart of overall study protocol. by Yongwoo Lee (2265172)

Subjects:

Surface displacements after shot peening in the finite element model for different projectile diameters: (a) 0.4 mm, (b) 0.6 mm, (c) 0.8 mm, (d) 1.0 mm, and (e) surface roughness P... by Huashen Guan (20454677)

Subjects:

qPCR (A-D) and ELISA (E-H) detection of inflammatory cytokines in intestine of <i>T. spiralis</i>-infected mice. by Wen Wen Zheng (17721404)

Subjects:

a Positive ion mode correlation heat map (A) Mild PTOA group VS Severe PTOA group (B) Mild PTOA group VS normal group (C) Severe PTOA group VS normal group. b. Negative ion mode co... by Peng-fei Han (694841)

Subjects:

iBAT characterization of the <i>aP2-Drp1</i>^f/f neonatal mice. by Yuta Ibayashi (20404811)

Subjects:

Change in the vertical distribution of the lipid layer thickness after intensive pulse light treatment (IPL; nm) combined with meibomian gland expression (MGX). by Yongwoo Lee (2265172)

Subjects:

The complex interplay between SGLT-2is, RAAS, and glucose metabolism in type 2 diabetes mellitus patients. by Ningning Wang (560944)

Subjects:

Changes of physical and biochemical indicators from baseline and difference between DKD and non-DKD patients. by Ningning Wang (560944)

Subjects:

Baseline characteristics between DKD and non-DKD patients. by Ningning Wang (560944)

Subjects:

Flow diagram of patient recruitment. by Ningning Wang (560944)

Subjects:

Multiple linear regression analysis of the RAAS and glucose metabolism indicators before and after treatment in DKD and non-DKD patients. by Ningning Wang (560944)

Subjects: